Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Non-Current Deffered Revenue: 2017-2018

Historic Non-Current Deffered Revenue for Cogent Biosciences (COGT) over the last 2 years, with Dec 2018 value amounting to $748,000.

  • Cogent Biosciences' Non-Current Deffered Revenue fell 91.42% to $748,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $748,000, marking a year-over-year decrease of 91.42%. This contributed to the annual value of $748,000 for FY2018, which is 91.42% down from last year.
  • Cogent Biosciences' Non-Current Deffered Revenue amounted to $748,000 in FY2018, which was down 91.42% from $8.7 million recorded in FY2017.
  • Cogent Biosciences' 5-year Non-Current Deffered Revenue high stood at $8.7 million for FY2017, and its period low was $748,000 during FY2018.
  • Moreover, its 2-year median value for Non-Current Deffered Revenue was $4.7 million (2017), whereas its average is $4.7 million.
  • Data for Cogent Biosciences' Non-Current Deffered Revenue shows a maximum YoY plummeted of 91.42% (in 2018) over the last 5 years.
  • Yearly analysis of 2 years shows Cogent Biosciences' Non-Current Deffered Revenue stood at $8.7 million in 2017, then crashed by 91.42% to $748,000 in 2018.